191
Participants
Start Date
June 1, 2011
Primary Completion Date
April 1, 2016
Study Completion Date
April 1, 2016
GSK933776
GSK933776
Placebo
Placebo
GSK Investigational Site, New York
GSK Investigational Site, West Mifflin
GSK Investigational Site, Philadelphia
GSK Investigational Site, Philadelphia
GSK Investigational Site, Baltimore
GSK Investigational Site, Baltimore
GSK Investigational Site, Charlottesville
GSK Investigational Site, Ladson
GSK Investigational Site, Augusta
GSK Investigational Site, Miami
GSK Investigational Site, Tampa
GSK Investigational Site, Stuart
GSK Investigational Site, Nashville
GSK Investigational Site, Louisville
GSK Investigational Site, Paducah
GSK Investigational Site, Indianapolis
GSK Investigational Site, New Albany
GSK Investigational Site, Detroit
GSK Investigational Site, Prairie Village
GSK Investigational Site, Leawood
GSK Investigational Site, Houston
GSK Investigational Site, Galveston
GSK Investigational Site, Austin
GSK Investigational Site, Abilene
GSK Investigational Site, Golden
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Phoenix
GSK Investigational Site, Phoenix
GSK Investigational Site, Torrance
GSK Investigational Site, Arcadia
GSK Investigational Site, La Jolla
GSK Investigational Site, Palm Desert
GSK Investigational Site, Irvine
GSK Investigational Site, San Francisco
GSK Investigational Site, Silverdale
GSK Investigational Site, Los Angeles
GSK Investigational Site, Boston
GSK Investigational Site, North Dartmouth
GSK Investigational Site, Northfield
GSK Investigational Site, Toms River
GSK Investigational Site, Mississauga
Lead Sponsor
GlaxoSmithKline
INDUSTRY